Severe transfusion-transmitted parvovirus B19 infection in a naive immunocompromised patient

Transplant Infectious Disease

Volumn 13, Issue 1, 2011, Pages 97-98

  Brodin Sartorius, A ^a   Mekki, Y ^b   Pastural, M ^a,c   Billaud, G ^b   Daoud, S ^a   Chauvet, C ^a   Touraine, J L ^a,d   Lina, B ^b,d   Morelon, E ^a,d   Thaunat, O ^a,d  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c AURAL   (France)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

Immunocompromised patients; Parvovirus B19; Transfusion

Indexed keywords

CORTISONE ACETATE PLUS NEOMYCIN; HEMOGLOBIN; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

AGED; APLASTIC ANEMIA; ARTHRITIS; BLOOD TRANSFUSION; CASE REPORT; ERYTHEMA INFECTIOSUM; FEVER; GENERAL CONDITION DETERIORATION; HEMOPERITONEUM; HUMAN; HUMAN PARVOVIRUS B19; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; MALE; NEUTROPHIL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTE; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 79551669845     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00546.x     Document Type: Letter

References (4)

1. Plentz A, Hahn J, Knoll A, Holler E, Jilg W, Modrow S. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion 2005; 45 (11): 1811-1815.
2. Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol 2007; 2 (Suppl 1): S47-S56.
3. Mortimer PP, Luban NL, Kelleher JF, Cohen BJ. Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet 1983; 2 (8348): 482-484.
4. Schmidt M, Themann A, Drexler C, et al. Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion 2007; 47 (10): 1775-1782.